Important safety considerations include: Gastrointestinal symptoms at higher doses Individual tolerance variability Potential for hypoglycaemia when combined with insulin or sulphonylureas Limited long-term safety data in humans Limited data in children and adolescents Patients with diabetes taking glucose-lowering medications should exercise caution when introducing allulose
Baskerville MJ, Kovalyova Y, Mejas-Luque R, Gerhard M, Hatzios SK
Practical tips for staying hydrated on weight loss medication: Keep a water bottle nearby and aim to sip consistently rather than drinking large amounts infrequently Monitor urine colour pale straw yellow is a good indicator of adequate hydration Avoid excessive alcohol, which can worsen dehydration If experiencing vomiting or diarrhoea, consider oral rehydration solutions to replace lost electrolytes If you are unable to maintain adequate fluid intake due to persistent vomiting or diarrhoea, contact your prescriber or seek medical advice promptly Kidney health deserves particular consideration
is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus, Ozempic and Wegovy
CORRECTION on video: Shortage was declared late 2022, not 2024 - Lillys tirzepatide patents start expiring in 2033
L'agente distaccante e il talco lubrificante utilizzato per la produzione di compresse o capsule possono contenere fibre di amianto
